Home
>
National Drug Code (NDC)
>
Deferoxamine Mesylate
Deferoxamine Mesylate - 0409-2336-13 - (Deferoxamine Mesylate)
Drug Information of Deferoxamine Mesylate
| Product NDC: | 0409-2336 |
| Proprietary Name: | Deferoxamine Mesylate |
| Non Proprietary Name: | Deferoxamine Mesylate |
| Active Ingredient(s): | 500 mg/1 & nbsp; Deferoxamine Mesylate |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Deferoxamine Mesylate
| Product NDC: | 0409-2336 |
| Labeler Name: | Hospira, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076019 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20040317 |
Package Information of Deferoxamine Mesylate
| Package NDC: | 0409-2336-13 |
| Package Description: | 10 VIAL, SINGLE-USE in 1 CARTON (0409-2336-13) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE |
NDC Information of Deferoxamine Mesylate
| NDC Code | 0409-2336-13 |
| Proprietary Name | Deferoxamine Mesylate |
| Package Description | 10 VIAL, SINGLE-USE in 1 CARTON (0409-2336-13) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE |
| Product NDC | 0409-2336 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Deferoxamine Mesylate |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Start Marketing Date | 20040317 |
| Marketing Category Name | ANDA |
| Labeler Name | Hospira, Inc. |
| Substance Name | DEFEROXAMINE MESYLATE |
| Strength Number | 500 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Iron Chelating Activity [MoA],Iron Chelator [EPC] |
